Evaluation of Effect of Rasayana Ghana Tablet (An Ayurvedic Formulation) in Management of Akala jara (Premature Ageing)
Keywords:
Rasayana Ghana tablet, Akala jara, premature ageing, guduchi, aamalaki, gokshuraAbstract
In the present era of stress, when lifestyle disorders are on the rise, premature ageing is also one of the most prevalent disorders. Ayurvedic Rasayana (rejuvenator) drugs can provide solution for this. The present study was aimed to evaluate the efficacy of Rasayana Ghana tablet (RGT) in management of premature ageing. In this placebo-controlled randomized prospective clinical study, Rasayana Ghana tablet based upon the classical combination of Gokshura (Tribulus terestris Linn.), Aamalaki (Embelica officinalis Gaertn.) and Guduchi (Tinospora cordifolia Miers.) was administered as trial drug with vehicle of ghee and honey. A total 108 patients of premature ageing fulfilling the criteria of inclusion as per ageing scale were selected and randomly divided into two groups. Group RGT (n = 56) was treated with Rasayana Ghana tablets. Two tablets (500 mg each) were given two times a day with the vehicle of ghee and honey for two months. In Placebo Group (PG) (n = 52), placebo tablets were administered in the same dose and for the same duration. Ageing scale based on gradations of classical ageing signs was utilized for assessment of results. The results were statistically analyzed by applying Chi square test and Wilcoxon’s signed rank test. RGT showed statistically significant improvement on (P < 0.001) of most of the ageing signs as compared to placebo. It can be concluded that RGT is effective in the management of premature ageing.
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |